Trimming & Sorting
Precision trimming and grading of cannabis flower to pharmaceutical specifications, ensuring uniformity and quality for every batch destined for global markets.
Somerset West, Western Cape
A specialist post-harvest facility that will transform GACP-compliant cannabis flower into medicinal cannabis products processed to EU-GMP principles — from cultivation partner to international market.
Who We Are
Delta-Nine Pharmaceuticals is a specialist post-harvest cannabis processing company based in Somerset West, Western Cape. We will partner with GACP-certified cultivation suppliers, selected through our supplier qualification process and operating under Quality/Technical Agreements, purchasing GACP-compliant cannabis flower and adding pharmaceutical value through a facility designed for GMP compliance.
Our mission is to ensure every processed batch meets the highest global standards for quality, safety, and consistency — enabling South African cultivators to access premium international markets with confidence.
What We Do
Precision trimming and grading of cannabis flower to pharmaceutical specifications, ensuring uniformity and quality for every batch destined for global markets.
Controlled environment drying and curing processes designed to preserve terpene profiles and cannabinoid integrity, and designed to meet strict moisture and microbiological standards.
Packaging, once licensed, under controlled GMP procedures in tamper-evident, pharmaceutical-grade containers with labelling in line with applicable regulatory requirements for the destination market.
Climate-controlled, secure vaulted storage with environmental monitoring and full chain-of-custody documentation from intake through to dispatch.
In-process testing and batch release procedures, once licensed, will be aligned with EU-GMP (EudraLex Volume 4) principles, with full documentation packages for regulatory submissions.
Once licensed, we will provide end-to-end export coordination including temperature-controlled transport, permits, and regulatory documentation for international pharmaceutical markets.
How It Works
We will source from GACP-certified cultivation suppliers, selected through our supplier qualification process and operating under Quality/Technical Agreements, verifying licence and GACP documentation before intake.
Once licensed, every incoming batch will be weighed, documented, and tested before entering our controlled processing environment. Batch records will be opened and chain of custody will begin.
Drying, curing, trimming, sorting, and grading will be performed in our facility, designed to pharmaceutical-grade standards, under controlled and monitored environmental conditions.
Once licensed, finished product will be packaged to EU-GMP specifications, labelled for target markets, and batch-released by our Responsible Pharmacist with full documentation.
Temperature-controlled logistics, import permits, and regulatory documentation will be coordinated for delivery to international pharmaceutical markets worldwide.
Our Milestones
Delta-Nine Pharmaceuticals incorporated in South Africa. Facility site selection and initial planning commenced in Somerset West, Western Cape.
CompletedProcessing facility constructed to pharmaceutical-grade specifications. Quality Management System development and SOP drafting initiated.
CompletedApplication submitted to SAHPRA in June 2026. Facility inspection readiness and compliance review underway.
In ProgressCommencement of commercial post-harvest processing for GACP-certified cultivation suppliers, selected through our supplier qualification process and operating under Quality/Technical Agreements. Initial batch records, QA protocols and supply agreements activated.
TargetStandards & Compliance
its not personal, its GMP
Our facility and processes are designed from the ground up to meet the rigorous requirements of both South African and international pharmaceutical regulators — so that product can be prepared to meet export market requirements.
Our operations are designed to meet SAHPRA licensing requirements and EU-GMP guidelines, with quality management, batch traceability, and environmental monitoring designed into every stage.
All incoming flower will be verified against the supplier's SAHPRA licence and GACP documentation before acceptance into our facility.
Processing rooms and controlled zones designed to Grade D, to maintain pharmaceutical-grade environmental conditions throughout processing.
Batch records will be kept from intake to release, designed to provide traceability for every unit produced.
Once licensed, batch release by our Responsible Pharmacist, with documentation packages prepared for target market submissions.
Get in Touch
Whether you're a GACP-compliant cultivator interested in becoming an approved supplier, or an international buyer seeking supply from a facility working towards EU-GMP certification, we'd like to hear from you.